Attendees
Sponsors and Exhibitors
Media
Contact us
The UK healthcare ICS Congress
The UK National ICS Congress
22-23 November 2023, London. This year’s central assembly of all ICS's leaders and stakeholders. Network with and learn from the leaders of the UK’s new ICS's - Integrated Care Systems, and meet the experts who are leading the dramatic and profound changes and innovation in the UK health sector.
The purpose of ICSs is to bring partner organizations together to:
- improve outcomes in population health and healthcare
- tackle inequalities in outcomes, experience, and access
- enhance productivity and value for money
- help the NHS support broader social and economic development.
Collaborating as ICSs will help health and care organizations tackle complex challenges, including:
- improving the health of children and young people
- supporting people to stay well and independent
- acting sooner to help those with preventable conditions
- supporting those with long-term conditions or mental health issues
- caring for those with multiple needs as populations age
- getting the best from collective resources so people get care as quickly as possible.
22-23 November 2023, London. This year’s central assembly of all ICS leaders and stakeholders. Network with and learn from the leaders of the UK’s new ICS's - Integrated Care Systems, and meet the experts who are leading the dramatic and profound changes and innovation in the UK health sector.
During the show, we will explore the obstacles, visions, and developments of integrated care systems, providing delegates with insights into how to move forward through a mixture of keynote addresses and best-practice case studies. It will provide an opportunity to understand the ICS strategy, consider government proposals, look at the connection of services, and uncover how this restructuring can deal with the COVID-19 backlog and overcome health inequalities.
ICS will be prioritising the reduction of health inequalities as a central focus of the ICS agenda, drawing on the widest possible range of levers to support these efforts
Focusing on strengthening the development of place-based partnerships and PCNs, with ICSs building up from these more local partnerships rather than becoming overly distracted by national asks
Ensuring the changes support genuine multiagency partnerships that span the NHS, local government, voluntary, community and social enterprise (VCSE) organisations and other partners, and that ICSs’ new responsibilities for NHS resources and performance don’t lead them to focus narrowly on the NHS in isolation
Previous
Next
The National Health Service (NHS) in the United Kingdom faces several challenges when it comes to procurement. Some of these include:
- Limited budgets: The NHS operates with tight budgets, which can limit the amount of money available for procurement.
- Complex regulations: The NHS is subject to a complex set of regulations, including EU procurement rules, which can make the procurement process more difficult.
- Lack of standardization: There is a lack of standardization in the procurement process across different NHS organizations, which can make it difficult for suppliers to understand the requirements of different organizations
- Limited supplier base: The NHS often relies on a limited number of suppliers, which can limit competition and increase prices.
- Long procurement cycles: The procurement process for the NHS can be slow, with long lead times for procurement and delivery of goods and services.
- Limited use of technology: The NHS has been slow to adopt modern procurement technologies, such as e-procurement systems, which can make the procurement process more efficient.
- Lack of transparency and accountability: The lack of transparency and accountability in the procurement process can make it difficult for stakeholders to understand how decisions are being made and who is responsible for them.
- Difficulty in measuring and evaluating performance: Measuring and evaluating the performance of suppliers is a challenge for the NHS, which can make it difficult to identify and address issues with suppliers.
ICSs will impact how you go about selling your goods and services to the NHS, but not as drastically as you might believe.
Going forward, it's important to think in the structures used by the NHS: namely, the aforementioned 'level' system. You should understand where your services or products sit in the Neighbourhood, Place and Systems tiers: if you offer FM services to a Trust, or sell services to individual GP practices, then it's likely you will sit at the Neighbourhood or Place level, and there will not be a huge change. However, if your services cross those boundaries - say, if you provide sexual health services - then it is likely that these will be commissioned at the ICS level.
How the introduction of ICSs affects health commissioning is largely contingent on just how 'Integrated' the Care Systems are. If truly integrated, procurement may become easier and more streamlined, particularly for organisations that can offer connectivity across a region like ourselves.
If properly integrated, the role of ICSs as regional 'strategy setters' will be a key consideration if you're looking to do business with the NHS. While suppliers will still need to engage with local providers, as has always been the case traditionally, suppliers will also need to ensure their products/solutions meet the wider ICS strategy and needs.
You'll need to consider the impact of your service or product on the wider healthcare economy: if you can demonstrate that you are able to help commissioners develop integrated pathways, and understand that care doesn't start and stop at the front door of a particular institution, then you will be in a stronger position.
As such, while the roll-out of ICSs won't have too drastic an impact on how you sell your goods and services to the NHS, understanding the role of ICSs, the strategies they're implementing, and how they're cultivating a more interconnected healthcare system is key to writing a smarter bid. A good bid will reference ICSs sensibly, a great one will understand how the service you provide fits into the new paradigm, and provides a better service for patients as a result.
THE UK NATIONAL ICS CONGRESS
Will take place on 22-23 November 2023 in central London.
This conference is part of The GIANT Health Event 2023
"Europe's largest and most valuable international festival
of health-tech innovation"
- Financial Times.
Established for 10 years, GIANT is a vibrant, engaged UK and European business community that enables and commercialises leading health-tech innovation from across the UK and Europe.
Innovate / Collaborate / Accelerate
We successfully bring together tech innovators, investors, global Pharma corporates, established SMEs, doctors, hospital managers, government health officials, and more; to spark productive business collaboration and accelerate better health outcomes.
Time |
|
Session Title and Description |
9:00 - 9:05 |
|
Welcome from our chairman Speaker  Professor Shafi Ahmed,
Consultant Colorectal Surgeon, Barts Health NHS Trust |
9:05 - 9:30 |
|
Integrating Excellence in NHS 111 with Herts Urgent Care: Developing Best Practice through a Long-Term Technology Partnership HUC is one of the country’s highest performing providers of NHS 111 and Integrated Urgent
& Emergency Care, serving 3.5 million people in the East of England. HUC’s digital
transformation journey has harnessed the power of collaboration and the cloud to deliver
multiple patient engagement breakthroughs. Join Martin Taylor, Deputy CEO of Content
Guru, to hear how HUC’s multi-award-winning six-year development partnership with
Content Guru has transformed the provider into a national beacon of innovation, in the
process reshaping the national technology landscape for Urgent Care service delivery in
England. Speaker   Martin Taylor,
Deputy CEO and Co-Founder, Content Guru |
| 9:30 - 10:15 | Data enabled health and care
Panel discussion by Newmarket Strategy Invited speakers: Moderator: Ele Harwich, Director, Newmarket Strategy Dan Onions, Global Head of Data Managemen, Quantexa Jess Morley, Director of Policy, Bennett Institute for Applied Data Science at Oxford University Linda Vernon, Acting Digital Culture and Transformation Clinical Lead, Lancashire and South Cumbria Health and Care Partnership (NHS) Speakers   Ele Harwich,
Director, Newmarket Strategy   Dan Onions,
Global Head of Data Management, Quantexa   Jessica Rose Morley,
Director of Policy, Bennett Institute for Applied Data Science at Oxford University   Linda Vernon,
Acting Digital Culture and Transformation Clinical Lead Lancashire and South Cumbria Health and Care Partnership (NHS) |
|
| 10:15 - 11:00 |
The value of the CNIO and what we can do for you Invited speakers:Moderator: Matthew Little, Chief Nurse Information Officer (CNIO), Worcestershire Acute Hospital NHS Trust Claire Madon RN MSc, Chief Nursing Information Officer, NHS England & NHS Improvement – Midlands Region
Speakers   Claire Madon RN MSc,
Chief Nursing Information Officer, NHS England & NHS Improvement – Midlands Region   Matthew Little,
Chief Nurse Information Officer (CNIO), Worcestershire Acute Hospital NHS Trust |
|
11:00 - 11:30 |
|
Panel discussion Moderator:Debashish Das, Consultant Cardiologist & Digital Transformation, Barts Hospital NHS Trust Gary McCallister, CTO for London Cathy Walters, Transformation Lead, Heart, Lung and Critical Care Clinical Group at Guy’s & St Thomas’ NHS Foundation Trust Martin yates Cardiothoracic Surgeon at Barts Health NHS Trust Speakers   Debashish Das,
Consultant Cardiologist & Digital Transformation, Barts Hospital NHS Trust  Gary McCallister,
CTO for London   Cathy Walters,
Transformation Lead, Heart, Lung and Critical Care Clinical Group at Guy’s & St Thomas’ NHS Foundation Trust
 Martin Yates,
Cardiothoracic Surgeon at Barts Health NHS Trust |
| 11:30 - 12:15 |
How to manage the growing tide of kidney disease Invited speakers:Moderator: Alex Merckx, Director of Marketing and Partnerships, Cognitant Emma Vaux, Medical Associate Director Patient Safety and Clinical director, Royal Berkshire NHS Foundation Trust Speakers   Emma Vaux,
Medical Associate Director Patient Safety and Clinical director, Royal Berkshire NHS Foundation Trust   Alex Merckx,
Director of Marketing and Partnerships, Cognitant |
|
| 12:15 - 13:00 |
A panel discussion presented by Vodafone and Deloitte Invited speakers:Moderator: Anne-Marie Vine-Lott, Head of Centre for Health Vodafone Gus Miah, Risk Advisory Lead Partner for Health, Deloitte Paul Maubach, Strategic Advisor ICS Collaboration, NHS Midlands Dr Priya Kumar, GP Partner Kumar Medical Centre, Health Inequalities Lead, Slough, Connected Care Clinical Lead Chaired by Professor Shafi Ahmed; Centre for Health Deloitte Partner, Gus Miah will be joined by 3 other panel members to discuss the role of technology and collaboration in accelerating solutions to tackle the elective care backlog – please join this lively debate   Gus Miah,
Risk Advisory Lead Partner for Health, Deloitte  Anne-Marie Vine-Lott,
Head of Centre for Health Vodafone  Paul Maubach,
Strategic Advisor ICS Collaboration, NHS Midlands  Dr Priya Kumar,
GP Partner Kumar Medical Centre, Health Inequalities Lead, Slough, Connected Care Clinical Lead |
|
13:00 - 14:30 |
Lunch and Networking |
|
14:30 - 15:00 |
|
|
| 15:00 - 15:30 | Remote Patient Monitoring to improve population health and equitable access to care Invited speakers:Moderator: David Kuraguntla, CEO and Co-founder Alio Ava Lim, Head of Partnerships, Alio Ken Callahan, Principal, Haragan Group, Former Chief of Staff, US Dept of Health and Human Services Colin Rom, Managing Director, Science and Innovation Policy, Mayo Clinic Rajesh Sivaprakasam, Lead for Robotic Renal Failure Surgery, Barts Health NHS Trust Moderator   Ava Lim,
Head of Partnerships, Alio Participants  David Kuraguntla,
CEO and Co-founder Alio Ken Callahan,
Principal, Haragan Group, Former Chief of Staff, US Dept of Health and Human Services  Colin Rom,
Managing Director, Science and Innovation Policy, Mayo Clinic Rajesh Sivaprakasam,
Lead for Robotic Renal Failure Surgery, Barts Health NHS Trust |
|
15:30 - 16:00 |
|
Leveraging AI and data driven technologies to deliver population-based care a panel discussion with our partner CMefy Speakers  Hatim Abdulhussein,
National Clinical Lead for AI & Digital Medical Workforce, HEE and Medical Director KSS AHSN   Niraj Swami,
CEO, CMEfy |
| 16:00 - 16:20 |
Research, development and innovation: a medical device for people with Parkinson's Speaker   Lucy Jung,
CEO, Charco Neurotech |
|
| 16:20 - 16:35 |
|
Managing comorbidity: from patient to population Speaker   Ian Wharton,
Founder, CEO, Aide Health |
| 16:35 - 17:00 |
Cross system collaboration for skin cancer diagnosis Invited speakers:Moderator: Rachael Dovey, NHS Lead, Skin Analytics Helen Mather, Associate Director Elective Cancer and Diagnostics, LLR ICB   Rachael Dovey,
NHS Lead, Skin Analytics   Helen Mather,
Associate Director Elective Cancer and Diagnostics, LLR ICB |
ICSs are intended to bring about major changes in how health and care services are planned, paid for, and delivered, and are a key part of the future direction for the NHS as set out in the NHS Long Term Plan.
The UK National ICS Congress is intending to serve as an enabler for ICSs to be a vehicle for achieving greater integration of health and care services; improving population health and reducing inequalities; supporting productivity and sustainability of services; and helping the NHS to support social and economic development.
ICSs are part of a fundamental shift in the way the health and care system is organised. ICSs depend on collaboration and a focus on places and local populations as the driving forces for improvement.
Time |
|
Session Title and Description |
09:45 - 10:00 |
|
|
| 10:00 - 11:30 |
|
|
| 11:30 - 13:00 |
|
|
| 13:00 - 14:30 |
|
|
| 14:30 - 15:30 |
|
|
| 15:30 - 17:30 |
|
Meet more people and learn more in one day than you will for the rest of the entire year.
If you are involved in the provision of healthcare in the UK this conference is a must attend. This important event is designed for all doctors, hospital managers, primary care partners and leaders, department of health personnel, and all new members of the individual ICSs and ICBs.
As the leading conference of 2023 convening all stakeholders involved in the new ICS and ICB structures, you will be able to network with and learn from the most important community of healthcare commissioners and meet the national leaders driving innovation and digital transformation.
See case studies of successful innovations in the new ICSs. Learn what is (and what is not) working in other ICSs across the country.
ICS will be prioritising the reduction of health inequalities as a central focus of the ICS agenda, drawing on the widest possible range of levers to support these efforts
Focusing on strengthening the development of place-based partnerships and PCNs, with ICSs building up from these more local partnerships rather than becoming overly distracted by national asks
Ensuring the changes support genuine multiagency partnerships that span the NHS, local government, voluntary, community and social enterprise (VCSE) organisations and other partners, and that ICSs’ new responsibilities for NHS resources and performance don’t lead them to focus narrowly on the NHS in isolation
Previous
Next
This event is for ICS Network members: ICB and ICP Chairs, CEOs, Directors, Advisorate members, and non-Exec Directors.
Sign up for GIANT 2023 to learn from top speakers, interactive breakout sessions, and most importantly network and share experience with your leader peers. We look forward to seeing you at our event
Learn
from series of high-level keynote presentations and case studies on how you can use new ICS to solve your and your clients' problems
Network
with fellow industry leaders who strive to be at the forefront of innovation and build long-lasting relationships
Drive
the next wave of innovation by liaising directly with leading ICS investors and providers to make sure your opinions and problems are heard
Discover
the most exciting new innovation from both disruptive startups and established market leaders before the rest of the world
Network
with fellow investors and mentors across multiple fields to share portfolio practices and discuss business goals
Build
unique market insights as you liaise directly with leading buyers and providers to help guide your future investment decisions
Showcase
your unique innovations through our stage and exhibitions to countless leading investors and buyers. Secure your spot now before they run out
Collaborate
with your buyers and investors directly to help guide new business opportunities and secure your product-market fit
Accelerate
and improve your development process by learning from the best practices of fellow industry leaders
We work with the world’s largest brands in healthcare technology, hardware, software, Pharma, and more, to provide impactful, direct engagement with leading health-tech innovators and healthcare providers. Examples of partners include Eli Lilly, Novartis, Barclays Bank, NHS, Microsoft, Bayer, Ascensia, Cedars Sinai, and McKinsey.
Our proud partnerships with our valued partners are testimony to GIANT’s international reputation as Europe’s leading “magnet for innovation” - BBC in the health sector.
Sponsors & exhibitors can build cost-effective sales, new business development, and marketing communication / brand-building programs on the foundation of the GIANT Health Event, accessing GIANT’s UK and European community of nearly 300,000 passionate healthcare innovators.
